7-OH.org
Industry Alert

⚠ "Cat's Claw" Product Warning

New brands falsely marketed as containing Cat's Claw (Rhynchophylline) — a plant that is NOT psychoactive — may actually contain MGM-15, MGM-16, or undisclosed synthetic pharmaceutical compounds that do not appear on standard drug tests. Consumers may be unknowingly ingesting dangerous experimental substances.

Kratom & 7-OH Legal and Health Resources

News, health information, and legal updates regarding kratom lawsuits and 7-OH class actions.

news3 min read

Texas AG Sues Kratom Retailers for Violating State Law Limits

Texas Attorney General Ken Paxton has filed lawsuits against retailers for selling kratom products that allegedly exceed state potency limits.

7-OH.org Legal AI
news3 min read

FDA Seizes 7-OH Opioids and Issues Warning Letters to Firms

The FDA is taking steps to restrict novel potent opioid products, including 7-OH, through seizures and warning letters to marketing firms.

7-OH.org Legal AI
news3 min read

Missouri Attorney General Files Suit Against Kratom Manufacturer Over MGM-15

Missouri AG Catherine Hanaway is suing a kratom manufacturer, alleging the sale of MGM-15, a compound claimed to be more potent than 7-OH.

7-OH.org Legal AI
news3 min read

DEA Notice of Intent to Schedule 7-OH and Synthetic Derivatives

The DEA issued notices of intent to temporarily control 7-hydroxymitragynine (7-OH) and related synthetic derivatives like MGM-15 due to high abuse potential.

7-OH.org Legal AI
news3 min read

DEA Announces Placement of Three 7-OH-Related Compounds as Schedule I Substances

The U.S. Drug Enforcement Administration has designated three 7-hydroxymitragynine-related compounds—mitragynine pseudoindoxyl, MGM-15, and MGM-16—as Schedule I substances.

7-OH.org Legal AI
news3 min read

What's the latest on 7-OH and kratom availability and addiction care?

Users of three synthetic opioids -- mitragynine pseudoindoxyl (MP), MGM-15, and MGM-16 -- will be unable to buy products containing them legally as of August 26, 2026.

7-OH.org Legal AI
news3 min read

DEA announces placement of three 7-OH -related compounds as Schedule I substances

Mitragynine pseudoindoxyl, MGM-15 and MGM-16 are being temporarily placed in Schedule I as federal officials target manufactured opioid products.

7-OH.org Legal AI
news3 min read

FDA Issues Warning Letters to Firms Marketing 7-OH Products

The FDA took action against companies marketing 7-hydroxymitragynine products to protect consumers.

7-OH.org Legal AI
news3 min read

Ohio Places 7-OH and MGM-15 in Schedule I

Ohio state regulators issued an emergency rule to classify 7-OH and related substances as controlled substances.

7-OH.org Legal AI
news3 min read

American Medical Association Calls for Ban on 7-OH Products

The AMA has adopted a policy urging the FDA to ban the sale and marketing of 7-hydroxymitragynine products.

7-OH.org Legal AI
news3 min read

Missouri Attorney General Sues Kratom Manufacturer Over MGM-15

Missouri AG Catherine Hanaway filed a lawsuit against EDP Kratom, citing the dangers of the potent compound MGM-15.

7-OH.org Legal AI
news3 min read

DEA Announces Intent to Schedule 7-Hydroxymitragynine (7-OH)

The DEA filed a Notice of Intent to temporarily place 7-OH above a specific threshold into Schedule I.

7-OH.org Legal AI
news3 min read

DEA Temporarily Schedules Synthetic Kratom-Related Products Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I

The DEA has officially placed three synthetic kratom derivatives into Schedule I, effective August 26, 2026.

7-OH.org Legal AI
news3 min read

Texas AG sues California kratom retailers for selling products he says violate state law

Attorney General Ken Paxton filed suit against retailers for allegedly selling kratom products that exceed state limits on alkaloid concentrations.

7-OH.org Legal AI
news3 min read

AMA Calls for Complete Ban on Sales of 7-OH

The American Medical Association has adopted a policy urging the FDA to ban the sale, distribution, and marketing of products containing the kratom alkaloid 7-OH.

7-OH.org Legal AI
news3 min read

Missouri kratom company destroys $10M in products after DEA crackdown

A Missouri-based kratom company destroyed millions of dollars worth of inventory following federal regulators' decision to place kratom-related opioids in Schedule I.

7-OH.org Legal AI
news3 min read

DEA to Temporarily Schedule 7-OH and Related Substances to Protect Public Safety

The U.S. Drug Enforcement Administration filed its intent to temporarily place 7-hydroxymitagynine (7-OH) and three related substances, including MGM-15, into Schedule I of the Controlled Substances Act.

7-OH.org Legal AI
news3 min read

Global Kratom Coalition Applauds DEA for Finalizing Temporary Scheduling Order

The Global Kratom Coalition supports the DEA's decision to schedule synthetic alkaloids while protecting access to natural kratom leaf.

7-OH.org Legal AI
news3 min read

DEA Will Classify 7-OH as Illegal Drug

The DEA is moving to ban concentrated forms of the kratom alkaloid 7-hydroxymitragynine, classifying it as a Schedule I substance.

7-OH.org Legal AI
news3 min read

DEA Bans MGPI, MGM-15 & MGM-16: What It Means for Kratom

The DEA has finalized emergency scheduling for synthetic kratom derivatives, making possession of products containing MGM-15 or MGM-16 a federal offense.

7-OH.org Legal AI